Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 2 (2006), Issue 7 (July)

1. Clinical and pathologic differential diagnosis of selected potential bioterrorism agents of interest to pediatric health care providers.
   Clin Lab Med, 26(2): 329-44, viii. [Abstract] [Full-text]
2. Evaluation of an online bioterrorism continuing medical education course.
   J Contin Educ Health Prof, 26(2): 137-44. [Abstract] [Full-text]
3. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
   Vaccine, 24(31): 5872-80. [Abstract] [Full-text]
4. Self-association of the transmembrane domain of an anthrax toxin receptor.
   J Mol Biol, 360(1): 145-56. [Abstract] [Full-text]
5. Mixed-type noncompetitive inhibition of anthrax lethal factor protease by aminoglycosides.
   FEBS J, 273(13): 3054-62. [Abstract] [Full-text]
6. Bacillus anthracis virulent plasmid pX02 genes found in large plasmids of two other Bacillus species.
   J Clin Microbiol, 44(7): 2367-77. [Abstract] [Full-text]
7. CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine.
   Expert Rev Vaccines, 5(3): 365-9. [Abstract] [Full-text]
8. Synthesis of polyvalent inhibitors of controlled molecular weight: structure-activity relationship for inhibitors of anthrax toxin.
   Biomacromolecules, 7(7): 2082-5. [Abstract] [Full-text]
9. Modeling the effects of a Staphylococcal Enterotoxin B (SEB) on the apoptosis pathway.
   BMC Microbiol, 6: 48. [Abstract] [Full-text]
10. Evaluation of the protective effects of quinacrine against Bacillus anthracis Ames.
    J Toxicol Environ Health A, 69(11): 1083-95. [Abstract] [Full-text]
11. Quantitative analysis of the effect of cell type and cellular differentiation on protective antigen binding to human target cells.
    FEBS Lett, 580(17): 4172-5. [Abstract] [Full-text]
12. Engineered chloroplasts as vaccine factories to combat bioterrorism.
    Trends Biotechnol, 24(8): 339-42. [Abstract] [Full-text]
13. Self-assembled "dock and lock" system for linking payloads to targeting proteins.
    Bioconjug Chem, 17(4): 912-9. [Abstract] [Full-text]
14. Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon.
    J Bacteriol, 188(15): 5333-44. [Abstract] [Full-text]
15. Cationic polyamines inhibit anthrax lethal factor protease.
    BMC Pharmacol, 6: 8. [Abstract] [Full-text]
16. Anthrax: a systematic review of atypical presentations.
    Ann Emerg Med, 48(2): 200-11. [Abstract] [Full-text]
17. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells.
    Mol Microbiol, 61(2): 324-37. [Abstract] [Full-text]
18. Treatment and prophylaxis of anthrax by new neurosecretory cytokines.
    Neurochem Res, 31(6): 795-803. [Abstract] [Full-text]
19. Immunization to protect the US Armed Forces: heritage, current practice, and prospects.
    Epidemiol Rev, 28: 3-26. [Abstract] [Full-text]
20. Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugates.
    Infect Immun, 74(8): 4744-9. [Abstract] [Full-text]
21. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
    Xenobiotica, 36(7): 597-613. [Abstract] [Full-text]
22. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
    Vaccine, 24(33): 5950-9. [Abstract] [Full-text]
23. Cisplatin inhibition of anthrax lethal toxin.
    Antimicrob Agents Chemother, 50(8): 2658-65. [Abstract] [Full-text]
24. Comparison of PCR, culture and microscopy of blood smears for the diagnosis of anthrax in sheep and cattle.
    Lett Appl Microbiol, 43(2): 181-6. [Abstract] [Full-text]
25. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.
    FEMS Immunol Med Microbiol, 47(3): 436-43. [Abstract] [Full-text]
26. Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages.
    FEMS Immunol Med Microbiol, 47(3): 369-79. [Abstract] [Full-text]
27. Observing local and global properties of metabolic pathways: 'load points' and 'choke points' in the metabolic networks.
    Bioinformatics, 22(14): 1767-74. [Abstract] [Full-text]
28. Nurses' beliefs about public health emergencies: fear of abandonment.
    Am J Infect Control, 34(6): 351-7. [Abstract] [Full-text]
29. Surgical infection society guidelines for vaccination after traumatic injury.
    Surg Infect (Larchmt), 7(3): 275-303. [Abstract] [Full-text]
30. Multiple vaccine and pyridostigmine interactions: effects on EEG and sleep in the common marmoset.
    Pharmacol Biochem Behav, 84(2): 282-93. [Abstract] [Full-text]
31. Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets.
    Pharmacol Biochem Behav, 84(2): 207-18. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.